NCT05557877 2026-01-06
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
11 trialsNCT04188119 2025-12-08
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
NCT02804815 2025-06-10
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
Phase 3 Active not recruiting
NCT02834403 2023-12-15
L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients
The Methodist Hospital Research Institute
Phase 1/2 Completed
NCT04038489 2021-11-22
Breast 51
University of Virginia
Phase 2 Withdrawn
NCT03794596 2019-07-22
IMpALA
The Christie NHS Foundation Trust
Phase 2 Withdrawn
NCT03491410 2018-04-09
Breast Cancer Active Surveillance, Alternative Option, Aspirin Included
Centro Hospitalar Lisboa Ocidental
Phase 2/3 Unknown
NCT00263211 2017-03-15
A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients
Washington University School of Medicine
Phase 2 Terminated
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT01431053 2013-03-13
Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT01612247 2012-06-05
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
University of Vermont
Phase NA Unknown